Integration of Nanotechnology with ctDNA: New Advances for Monitoring Neoadjuvant Chemotherapy
: The evaluation of tumor response in the neoadjuvant chemotherapy (NACT) is still difficult as traditional imaging techniques can only provide morphological information at discrete intervals, and pathological response is usually assessed only after surgery. Although circulating tumor DNA (ctDNA) has the potential to p...